PARAGON 28 INC (FNA)
US69913P1057 - Common Stock
We assign a fundamental rating of 3 out of 10 to FNA. FNA was compared to 188 industry peers in the Health Care Equipment & Supplies industry. FNA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FNA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year FNA has reported negative net income.
FNA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: FNA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: FNA reported negative operating cash flow in multiple years.
1.2 Ratios
FNA's Return On Assets of -19.03% is in line compared to the rest of the industry. FNA outperforms 52.41% of its industry peers.
FNA has a Return On Equity of -40.23%. This is comparable to the rest of the industry: FNA outperforms 52.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.03% | ||
| ROE | -40.23% | ||
| ROIC | N/A |
ROA(3y)-15.46%
ROA(5y)-7.89%
ROE(3y)-27.27%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
FNA's Gross Margin of 76.67% is amongst the best of the industry. FNA outperforms 89.84% of its industry peers.
FNA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FNA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.05%
GM growth 5YN/A
2. Health
2.1 Basic Checks
FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNA has more shares outstanding
FNA has a worse debt/assets ratio than last year.
2.2 Solvency
FNA has an Altman-Z score of 2.38. This is not the best score and indicates that FNA is in the grey zone with still only limited risk for bankruptcy at the moment.
FNA's Altman-Z score of 2.38 is fine compared to the rest of the industry. FNA outperforms 63.10% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that FNA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.75, FNA is not doing good in the industry: 73.80% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.38 |
ROIC/WACCN/A
WACC8.79%
2.3 Liquidity
A Current Ratio of 3.57 indicates that FNA has no problem at all paying its short term obligations.
FNA's Current ratio of 3.57 is fine compared to the rest of the industry. FNA outperforms 60.96% of its industry peers.
A Quick Ratio of 1.70 indicates that FNA should not have too much problems paying its short term obligations.
FNA has a Quick ratio (1.70) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.57 | ||
| Quick Ratio | 1.7 |
3. Growth
3.1 Past
FNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.98%.
The Revenue has grown by 19.29% in the past year. This is quite good.
FNA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.92% yearly.
EPS 1Y (TTM)-48.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)19.29%
Revenue growth 3Y24.92%
Revenue growth 5YN/A
Sales Q2Q%18.11%
3.2 Future
The Earnings Per Share is expected to grow by 6.10% on average over the next years.
FNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.51% yearly.
EPS Next Y-16.95%
EPS Next 2Y8.08%
EPS Next 3Y14.64%
EPS Next 5Y6.1%
Revenue Next Year16.34%
Revenue Next 2Y16.35%
Revenue Next 3Y16.22%
Revenue Next 5Y18.51%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
FNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
FNA's earnings are expected to grow with 14.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.08%
EPS Next 3Y14.64%
5. Dividend
5.1 Amount
FNA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PARAGON 28 INC
NYSE:FNA (11/13/2024, 8:04:01 PM)
After market: 10.3 0 (0%)10.3
+2.8 (+37.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap860.05M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.03% | ||
| ROE | -40.23% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.67% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.57 | ||
| Quick Ratio | 1.7 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-48.98%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-16.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.29%
Revenue growth 3Y24.92%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y